Compound Monoammonium Glycyrrhizinate Injection
Function and Efficacy
Glycyrrhizic acid monoamine has a strong affinity for steroid metabolic enzymes in the liver, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory effects, anti-allergic effects, and protective membrane structures; there are no obvious corticosteroid-like adverse reactions. This product can promote monochrome metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reactions; inhibit the production and formation of free radicals and lipid peroxides, and reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria
Ingredients
This product is a compound preparation, and its components are: each 1 ml contains 2 mg of monoammonium glycyrrhizinate (C42H65NO16·2H2O), 1.5 mg of L-cysteine hydrochloride (C3H7NO2S·HCl·H2O), and 20 mg of glycine (C2H5NO2).
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Glycyrrhizic acid ammonium saltIngredients |
It has a strong affinity for steroid metabolic enzymes in the liver, hinders the inactivation of cortisol and aldosterone, shows obvious corticosteroid-like effects (such as anti-inflammatory, anti-allergic and protective membrane structure, etc.), and has no obvious corticosteroid-like adverse reactions; promotes monochromatic metabolism, reduces the release of ALT and AST; induces γ-IFN and interleukin II, increases NK cell activity and the OKT4/OKT8 ratio and activates the reticuloendothelial system; inhibits the release of histamine from mast cells; inhibits the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reactions; inhibits the production and formation of free radicals and lipid peroxides, and reduces the activity of prolyl hydroxylase; regulates calcium ion channels, and protects lysosomal membranes and mitochondria. More |
53956-04-0 | 9 | |
| L-Cysteine hydrochloride monohydrateIngredients |
Glycyrrhizic acid monoamine has a strong affinity for steroid metabolic enzymes in the liver, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory effects, anti-allergic effects, and protective membrane structures; there are no obvious corticosteroid-like adverse reactions. This product can promote monochrome metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reactions; inhibit the production and formation of free radicals and lipid peroxides, and reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria More |
7048-04-6 | 4 | |
| GlycineIngredients |
Glycyrrhizic acid monoamine has a strong affinity for steroid metabolic enzymes in the liver, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory effects, anti-allergic effects, and protective membrane structures; there are no obvious corticosteroid-like adverse reactions. This product can promote monochrome metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reactions; inhibit the production and formation of free radicals and lipid peroxides, and reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria More |
56-40-6 | 27 |
Indication
It is used for abnormal liver function caused by acute and chronic hepatitis; it has a certain auxiliary therapeutic effect on toxic hepatitis. It can also be used for food poisoning, drug poisoning, drug allergy, etc.
Usage and Dosage
Intravenous drip. 20-80 ml at a time, add 5% glucose or 0.9% sodium chloride 250-500 ml injection solution to dilute, and slowly drip. Once a day. Intravenous injection. 20-80 ml at a time, add an equal amount of 5% glucose injection solution, and slowly push intravenously. Once a day.
Adverse Reactions
Poor appetite, nausea, vomiting, abdominal distension, itchy skin, urticaria, dry mouth and edema, water and sodium retention, hypokalemia, pseudoaldosteronism, common headache, dizziness, palpitations and increased hypertension in the cardiovascular and cerebrovascular system. The above symptoms are generally mild and do not affect treatment. Occasionally, chest tightness, thirst and allergic reactions may occur.
Precautions
1. Patients who are allergic to this product are prohibited from using this product. 2. Patients with severe hypokalemia and hypernatremia are prohibited from using this product. 3. Patients with hypertension and heart failure are prohibited from using this product. 4. Patients with renal failure are prohibited from using this product. 5. Patients with aldosteronism and tumors are prohibited from using this product.
Drug Interactions
Hypokalemia is likely to occur when used in combination with furosemide (Lasix) or thiazide diuretics.
Storage
Keep tightly closed in a cool, dark place.
Packaging Specification
20 ml
Manufacturer
M&C International Trading Limited
-
Founded in:
2002-12-17 -
Address:
No. 15, Gaoke Road, Hunnan New District, Shenyang -
Tax NO.:
91210112742738477H -
Registered Funds:
$7.72 million -
Website:
-
Email: